A

Angiex Inc.

12 employees

Angiex was founded by world-class scientists to develop vascular-targeted biotherapeutics.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Antibody-Drug Conjugates
Therapeutics
Oncology
Nuclear-Delivered Antibody-Drug ConjugatesTM
ADCs
Nuclear Delivery PlatformTM
Cancer

Date founded

2015

Funding rounds raised

Total raised

$25M

from 4 investors over 4 rounds

A

Angiex Inc. raised $25M on April 9, 2021

Investors: Presight Capital and Thiel Capital

A

Angiex Inc. raised $2M on October 8, 2020

Investors: Presight Capital

A

Angiex Inc. raised $3M on July 3, 2017

Investors: Thiel Capital

FAQ